Drug Profile
Ammonium lactate - Bristol-Myers Squibb
Alternative Names: BMS-186091; Lac-HydrinLatest Information Update: 16 Jan 2008
Price :
$50
*
At a glance
- Originator Bristol-Myers Squibb
- Class Lactates; Sulfhydryl compounds
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Marketed Dry skin; Ichthyosis
- Discontinued Photodamage
Most Recent Events
- 16 Oct 2000 Launched for Ichthyosis in USA (Topical)
- 16 Oct 2000 Launched for Xerosis cutis in USA (Topical)
- 28 Apr 1998 Phase-III clinical trials for Photodamage in USA (Topical)